60. Aplastic anemia Clinical trials / Disease details
Clinical trials : 245 / Drugs : 318 - (DrugBank : 86) / Drug target genes : 44 - Drug target pathways : 166
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR2000031933 | 2020-04-14 | 2020-04-15 | Foscarnet sodium for the treatment of pure erythrocyte aplastic anemia due to parvovirus B19 infection after kidney transplantation:study protocol for a prospective single-center trial | Foscarnet sodium for the treatment of pure erythrocyte aplastic anemia due to parvovirus B19 infection after kidney transplantation:study protocol for a prospective single-center trial | Pure red blood cell aplastic anemia after kidney transplant | case series:Foscarnet ( IV.); | The First Affiliated Hospital of Zhejiang University School of Medicine | NULL | Pending | Both | case series:20; | China |